|
Market Closed -
Euronext Paris
10:25:00 03/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0750 EUR | 0.00% |
|
+27.55% | -43.61% |
| 29/10 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 12/10 | ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6L | - | - | - | - | - |
| 6.22TCr | |||||
| 5.53TCr | |||||
| 5.49TCr | |||||
| 4.26TCr | |||||
| 4.11TCr |
- Stock Market
- Stocks
- ALINT Stock
- Charts IntegraGen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
